BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35230981)

  • 1. Acute liver injury following methylprednisolone pulse therapy: 13 cases from a prospectively collected cohort.
    Allgeier J; Weber S; Todorova R; Neumann J; Gerbes A
    Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):457-461. PubMed ID: 35230981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
    Weber S; Gerbes AL
    Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
    Weber S; Benesic A; Rotter I; Gerbes AL
    Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitis.
    Kimura H; Takeda A; Kikukawa T; Hasegawa I; Mino T; Uchida-Kobayashi S; Ohsawa M; Itoh Y
    Mult Scler Relat Disord; 2020 Jul; 42():102065. PubMed ID: 32259746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-induced autoimmune-like liver injury].
    Weber S
    Inn Med (Heidelb); 2024 Apr; 65(4):334-339. PubMed ID: 38374310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
    Andrade RJ; Aithal GP; de Boer YS; Liberal R; Gerbes A; Regev A; Terziroli Beretta-Piccoli B; Schramm C; Kleiner DE; De Martin E; Kullak-Ublick GA; Stirnimann G; Devarbhavi H; Vierling JM; Manns MP; Sebode M; Londoño MC; Avigan M; Robles-Diaz M; García-Cortes M; Atallah E; Heneghan M; Chalasani N; Trivedi PJ; Hayashi PH; Taubert R; Fontana RJ; Weber S; Oo YH; Zen Y; Licata A; Lucena MI; Mieli-Vergani G; Vergani D; Björnsson ES;
    J Hepatol; 2023 Sep; 79(3):853-866. PubMed ID: 37164270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.
    Björnsson ES; Medina-Caliz I; Andrade RJ; Lucena MI
    Hepatol Commun; 2022 Aug; 6(8):1895-1909. PubMed ID: 35596597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
    Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-induced autoimmune hepatitis: A minireview.
    Tan CK; Ho D; Wang LM; Kumar R
    World J Gastroenterol; 2022 Jun; 28(24):2654-2666. PubMed ID: 35979160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
    García-Cortés M; Ortega-Alonso A; Matilla-Cabello G; Medina-Cáliz I; Castiella A; Conde I; Bonilla-Toyos E; Pinazo-Bandera J; Hernández N; Tagle M; Nunes V; Parana R; Bessone F; Kaplowitz N; Lucena MI; Alvarez-Alvarez I; Robles-Díaz M; Andrade RJ
    Liver Int; 2023 Aug; 43(8):1749-1760. PubMed ID: 37269163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herb-induced autoimmune-like hepatitis associated with Xiang-tian-guo (Swietenia macrophylla seeds): A case report and literature review.
    Shao YM; Zhang Y; Yin X; Qin TT; Jin QL; Wen XY
    Medicine (Baltimore); 2021 Jan; 100(2):e24045. PubMed ID: 33466156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury.
    Tsutsui A; Harada K; Tsuneyama K; Senoh T; Nagano T; Takaguchi K; Ando M; Nakamura S; Mizobuchi K; Kudo M
    Dig Dis; 2017; 35(6):506-514. PubMed ID: 29040982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of a liver biopsy in patients with an acute liver failure or acute liver injury.
    Hunyady P; Herrmann E; Bojunga J; Friedrich-Rust M; Pathil A; Zeuzem S; Mihm U
    Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):801-806. PubMed ID: 35482907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis.
    Ju HY; Jang JY; Jeong SW; Woo SA; Kong MG; Jang HY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Jin SY; Kim HS; Kim BS
    Clin Mol Hepatol; 2012 Jun; 18(2):213-8. PubMed ID: 22893872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of synthetic oestrogen-induced autoimmune hepatitis with microvesicular steatosis.
    Morii K; Nishisaka M; Nakamura S; Oda T; Aoyama Y; Yamamoto T; Kishida H; Okushin H; Uesaka K
    J Clin Pharm Ther; 2014 Oct; 39(5):573-6. PubMed ID: 24989642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
    Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The progression of chronicity and autoimmune hepatitis in recurrent drug-induced liver injury.
    He T; Ren L; Gong M; Guo Y; Wang L; Xiao X; Wang R; Bai Z
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102009. PubMed ID: 35977662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.
    Hisamochi A; Kage M; Ide T; Arinaga-Hino T; Amano K; Kuwahara R; Ogata K; Miyajima I; Kumashiro R; Sata M; Torimura T
    J Gastroenterol; 2016 Jun; 51(6):597-607. PubMed ID: 26519284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced liver injury with autoimmune features complicated with hemophagocytic syndrome.
    Hayashi M; Abe K; Imaizumi H; Okai K; Kanno Y; Takahashi A; Ohira H
    Clin J Gastroenterol; 2016 Jun; 9(3):150-5. PubMed ID: 27076346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis].
    Zhao SX; Zhang YG; Tan PF; Wang RQ; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):302-6. PubMed ID: 27470631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.